{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:37:48Z","timestamp":1776109068627,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,8,26]],"date-time":"2006-08-26T00:00:00Z","timestamp":1156550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2006,9,5]]},"DOI":"10.1007\/s00125-006-0359-4","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T12:14:14Z","timestamp":1156508054000},"page":"2256-2262","source":"Crossref","is-referenced-by-count":89,"title":["Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes"],"prefix":"10.1007","volume":"49","author":[{"given":"L.","family":"Tarnow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Gall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. V.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hovind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-H.","family":"Parving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,26]]},"reference":[{"key":"359_CR1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/archinte.164.18.1978","volume":"164","author":"JA Doust","year":"2004","unstructured":"Doust JA, Glasziou PP, Pietrzak E, Dobson AJ (2004) A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164:1978\u20131984","journal-title":"Arch Intern Med"},{"key":"359_CR2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.330.7492.625","volume":"330","author":"JA Doust","year":"2005","unstructured":"Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330:625","journal-title":"BMJ"},{"key":"359_CR3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","volume":"350","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Larson MG, Levy D et al (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655\u2013663","journal-title":"N Engl J Med"},{"key":"359_CR4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","volume":"310","author":"CE Mogensen","year":"1984","unstructured":"Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310:356\u2013360","journal-title":"N Engl J Med"},{"key":"359_CR5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00400995","volume":"34","author":"M-A Gall","year":"1991","unstructured":"Gall M-A, Rossing P, Sk\u00f8tt P et al (1991) Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:655\u2013661","journal-title":"Diabetologia"},{"key":"359_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00125-004-1595-0","volume":"48","author":"L Tarnow","year":"2005","unstructured":"Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving H-H (2005) Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy. Diabetologia 48:149\u2013155","journal-title":"Diabetologia"},{"key":"359_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00125-004-1607-0","volume":"48","author":"P G\u00e6de","year":"2005","unstructured":"G\u00e6de P, Hildebrandt P, Hess G, Parving H-H, Pedersen O (2005) Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia 48:156\u2013163","journal-title":"Diabetologia"},{"key":"359_CR8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/diab.44.11.1303","volume":"44","author":"M-A Gall","year":"1995","unstructured":"Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H (1995) Albuminuria and poor glycemic control predicts mortality in NIDDM. Diabetes 44:1303\u20131309","journal-title":"Diabetes"},{"key":"359_CR9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","volume":"51","author":"CD Stehouwer","year":"2002","unstructured":"Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157\u20131165","journal-title":"Diabetes"},{"key":"359_CR10","first-page":"645","volume":"27","author":"GA Rose","year":"1962","unstructured":"Rose GA (1962) The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 27:645\u2013658","journal-title":"Bull WHO"},{"key":"359_CR11","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.CIR.21.6.1160","volume":"21","author":"H Blackburn","year":"1960","unstructured":"Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S (1960) The electrocardiogram in population studies: a classification system. Circulation 21:1160\u20131175","journal-title":"Circulation"},{"key":"359_CR12","first-page":"92","volume":"3","author":"C Christensen","year":"1984","unstructured":"Christensen C, \u00d8rskov C (1984) Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diab Nephropathy 3:92\u201394","journal-title":"Diab Nephropathy"},{"key":"359_CR13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(95)91747-0","volume":"346","author":"CE Mogensen","year":"1995","unstructured":"Mogensen CE, Keane WF, Bennett PH et al (1995) Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080\u20131084","journal-title":"Lancet"},{"key":"359_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-4347(00)81481-4","volume":"182","author":"HB Mortensen","year":"1980","unstructured":"Mortensen HB (1980) Quantitative determination of hemoglobin A1c by thinlayer isoelectric focusing. J Chromatogr 182:325\u2013333","journal-title":"J Chromatogr"},{"key":"359_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"359_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cccn.2005.04.031","volume":"360","author":"G Hess","year":"2005","unstructured":"Hess G, Runkel S, Zdunek D, Hitzler WE (2005) Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): A study in blood donors. Clin Chim Acta 360:187\u2013193","journal-title":"Clin Chim Acta"},{"key":"359_CR17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","volume":"362","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, Swedberg K, Granger CP et al (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet 362:759\u2013766","journal-title":"Lancet"},{"key":"359_CR18","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/ndt\/gfg253","volume":"18","author":"R Dikow","year":"2003","unstructured":"Dikow R, Ritz E (2003) Cardiovascular complications in the diabetic patient with renal disease: an update in 2003. Nephrol Dial Transplant 18:1993\u20131998","journal-title":"Nephrol Dial Transplant"},{"key":"359_CR19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF00281993","volume":"28","author":"K Borch-Johnsen","year":"1985","unstructured":"Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590\u2013596","journal-title":"Diabetologia"},{"key":"359_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1464-5491.2003.00948.x","volume":"20","author":"A Siebenhofer","year":"2003","unstructured":"Siebenhofer A, Ng LL, Plank J, Berghold A, Hodl R, Pieber TR (2003) Plasma N-terminal pro-brain natriuretic peptide in Type 1 diabetic patients with and without diabetic nephropathy. Diabet Med 20:535\u2013539","journal-title":"Diabet Med"},{"key":"359_CR21","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/jcem.84.7.5819","volume":"84","author":"Y Yano","year":"1999","unstructured":"Yano Y, Katsuki A, Gabazza EC et al (1999) Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 84:2353\u20132356","journal-title":"J Clin Endocrinol Metab"},{"key":"359_CR22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1056-8727(01)00173-8","volume":"16","author":"H Asakawa","year":"2002","unstructured":"Asakawa H, Fukui T, Tokunaga K, Kawakami F (2002) Plasma brain natriuretic peptide levels in normotensive Type 2 diabetic patients without cardiac disease and macroalbuminuria. J Diabetes Complications 16:209\u2013213","journal-title":"J Diabetes Complications"},{"key":"359_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjorland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29\u201334","journal-title":"Am J Cardiol"},{"key":"359_CR24","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/diacare.27.10.2398","volume":"27","author":"AH Wu","year":"2004","unstructured":"Wu AH, Omland T, Duc P et al (2004) The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study. Diabetes Care 27:2398\u20132404","journal-title":"Diabetes Care"},{"key":"359_CR25","doi-asserted-by":"crossref","first-page":"II97","DOI":"10.1161\/01.HYP.9.2_Pt_2.II97","volume":"9","author":"RB Devereux","year":"1987","unstructured":"Devereux RB, Liebson PR, Horan MJ (1987) Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 9:II97\u2013II104","journal-title":"Hypertension"},{"key":"359_CR26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669\u2013677","journal-title":"N Engl J Med"},{"key":"359_CR27","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1161\/01.CIR.0000130845.38133.8F","volume":"109","author":"MM Redfield","year":"2004","unstructured":"Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr (2004) Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 109:3176\u20133181","journal-title":"Circulation"},{"key":"359_CR28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2004.12.058","volume":"45","author":"LL Ng","year":"2005","unstructured":"Ng LL, Loke IW, Davies JE et al (2005) Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol 45:1043\u20131050","journal-title":"J Am Coll Cardiol"},{"key":"359_CR29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1464-5491.2004.01396.x","volume":"22","author":"NH Andersen","year":"2005","unstructured":"Andersen NH, Poulsen SH, Knudsen ST, Heickendorff L, Mogensen CE (2005) NT-proBNP in normoalbuminuirc patients with type 2 diabetes mellitus. Diab Med 22:188\u2013195","journal-title":"Diab Med"},{"key":"359_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ahj.2004.06.021","volume":"149","author":"ZY Fang","year":"2005","unstructured":"Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH (2005) Screening for heart disease in diabetic subjects. Am Heart J 149:349\u2013354","journal-title":"Am Heart J"},{"key":"359_CR31","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.2337\/diacare.26.7.2081","volume":"26","author":"V Epshteyn","year":"2003","unstructured":"Epshteyn V, Mudalier S, Morrison K et al (2003) Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26:2081\u20132087","journal-title":"Diabetes Care"},{"key":"359_CR32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacc.2004.05.071","volume":"44","author":"MA Bhalla","year":"2004","unstructured":"Bhalla MA, Chiang A, Epshteyn V et al (2004) Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol 44:1047\u20131052","journal-title":"J Am Coll Cardiol"},{"key":"359_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00125-004-1603-4","volume":"48","author":"AS Astrup","year":"2005","unstructured":"Astrup AS, Kim WY, Tarnow L et al (2005) Cardiac function and mass in asymptomatic type 1 diabetic patients with diabetic nephropathy in relation to NT-proBNP\u2014a cardiovascular magnetic resonance study. Diabetologia 48:8 (Abstract)","journal-title":"Diabetologia"},{"key":"359_CR34","first-page":"1777","volume-title":"The Kidney","author":"H-H Parving","year":"2003","unstructured":"Parving H-H, \u00d8sterby R, Ritz E (2003) Diabetic nephropathy. In: Brenner BM (ed) The Kidney, 7th edn. Saunders, Philadelphia, pp 1777\u20131818","edition":"7"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-006-0359-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0359-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:45:53Z","timestamp":1558597553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-006-0359-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,26]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,9,5]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s00125-006-0359-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,26]]}}}